NCT06582719

Brief Summary

The purpose of this study is to assess whether an AI based counseling service can be beneficial for patients to assist in management of gestational diabetes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started May 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress59%
May 2025Jan 2027

First Submitted

Initial submission to the registry

August 30, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 3, 2024

Completed
9 months until next milestone

Study Start

First participant enrolled

May 29, 2025

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

June 13, 2025

Status Verified

June 1, 2025

Enrollment Period

1.6 years

First QC Date

August 30, 2024

Last Update Submit

June 10, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Birth weight at time of Delivery

    Newborns will be weighed within 12 hours of the time of delivery. Birth weights will be summarized and reported by study group using basic descriptive statistics. Higher birth weights have been associated with Gestational Diabetes Mellitus (GDM) and increased risk of perinatal complications.

    Within 12 hours of delivery

Secondary Outcomes (4)

  • Rate of Neonatal Intensive Care Unit (NICU) admissions

    Within 12 hours of delivery

  • Rate of Cesarean Section

    Within 12 hours of delivery

  • Rate of Progression to medication requirements

    At the time of delivery

  • Rate of Shoulder Dystocia

    Within 12 hours of delivery

Study Arms (2)

Nutritional Counseling plus AI Intervention

EXPERIMENTAL
Device: GPT-based counselingOther: Nutritional Counseling

Nutritional Counseling

ACTIVE COMPARATOR
Other: Nutritional Counseling

Interventions

AI-based counseling provided to the patient, accessible on their smartphone device at the time of Gestational Diabetes diagnosis

Nutritional Counseling plus AI Intervention

Standard Nutritional Counselling provided by a registered dietician at the time of Gestational Diabetes diagnosis

Nutritional CounselingNutritional Counseling plus AI Intervention

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly pregnant women are elligible
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Women aged 18-45
  • Diagnosed with GDM in pregnancy
  • Able to use a smartphone
  • Fluent in English or Spanish

You may not qualify if:

  • Pre-existing diabetes
  • High-risk pregnancies due to other medical conditions
  • Inability to consent
  • Non-English and/or Non-Spanish speakers
  • No smartphone access

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Montefiore Medical Center

The Bronx, New York, 10461, United States

RECRUITING

Related Publications (2)

  • Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol. 1996 Feb;87(2):163-8. doi: 10.1016/0029-7844(95)00386-X.

    PMID: 8559516BACKGROUND
  • Centers for Disease Control and Prevention (CDC). (2022). National Diabetes Statistics Report

    BACKGROUND

MeSH Terms

Conditions

Diabetes, Gestational

Interventions

Nutrition Assessment

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationEpidemiologic MeasurementsPublic HealthEnvironment and Public Health

Study Officials

  • Dimitrios Mastrogiannis, MD

    Albert Einstein College of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Avish Arora, MD/PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 30, 2024

First Posted

September 3, 2024

Study Start

May 29, 2025

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

January 1, 2027

Last Updated

June 13, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations